ISTH 2021 Congress Archives - Page 4 of 91

Abstract Number: OC 56.3

Identification and Characterization of F9 Deep Intronic Variations in Haemophilia B Patients

A. Dericquebourg^1,2, M. Fretigny¹, C. Negrier^1,2, C. Vinciguerra^1,2, Y. Jourdy^1,2
Abstract Number: PB0813

Identification of a Common PROC Gene Mutation in Children with Moyamoya Disease Using Whole Exome Sequencing

N. Sirachainan¹, P. Pongphitcha¹, Y. Okuno², L. Thampratankul¹, C. Khongkhatithum¹, P. Komvilaisak³, T. Tim-Aroon¹, D. Songdej¹, D. Wattanasirichaigoon¹.
Abstract Number: PB0112

Identification of a Novel PROC Mutation in a Newborn Causing Severe Protein C Deficiency Successfully Treated with Liver Transplantation

A. Le Moigne¹, D. Habes², G. Hery³, G. Staiti⁴, V. Fouquet³, C. Baujard⁴, J. Miatello⁴, P. Durand⁴, M. Alhenc-Gelas⁵, O. Ackermann², D. Mitanchez⁶, G. Leverger¹, R. Favier⁷, V. Proulle⁸, M. Simonin¹
Abstract Number: PB0903

Identification of ADP P2y12 Receptor Defect by Functional Assays Using Algorithmic Approach – A Case Series

R. Dave¹, T. Geevar¹, J. Mammen¹, R. Vijayan¹, A. Samuel¹, S. Singh¹, S. Nair¹
Abstract Number: OC 37.2

Identification of an Alternate Covalent Form of Platelet αIIbβ3 Integrin that Selectively Partitions into Focal Adhesions where it Has Extended Residency Time and Altered Function

A.E. Pijning¹, M.T. Blyth², M. Coote², F. Passam³, J. Chiu¹, P.J. Hogg¹
Abstract Number: PB0960

Identification of Marginal Zone B Cells as Key Players in a Mouse Model of Platelet Alloimmunization

A. Couvidou¹, C. Angenieux¹, L. Ruch¹, C. Gachet¹, B. Maitre¹
Abstract Number: OC 21.4

Identification of Novel Variants by Panel-based High-throughput Sequencing Associated with Platelet Function Disorders

H. Schulze¹, G. Manukjan¹, A. Borst², E. Klopocki², O. Andres³, GPOH/GTH study group of Inherited Platelet Disorders
Abstract Number: OC 23.4

Identification of Patients at High Thrombotic Risk in a Large Prospective Cancer Patient Cohort Undergoing Anticancer Treatment

C. Verzeroli¹, M. Marchetti¹, S. Bolognini¹, S. Gamba¹, C. Giaccherini¹, L. Russo¹, C.J. Tartari¹, D. Spinelli², P. Malighetti², A. Santoro³, F. De Braud⁴, G. Gasparini⁵, M. Minelli⁶, C. Tondini⁷, R. Labianca⁸, F. Giuliani⁹, F. Petrelli¹⁰, S. Barni¹⁰, A. Falanga¹, A. D'Alessio¹¹
Abstract Number: LPB0088

Identification of Small Interfering RNAs for Allele-selective Silencing of Murine von Willebrand Factor

Y.K. Jongejan¹, R.J. Dirven¹, A. de Jong¹, B.J.M. van Vlijmen¹, J.C.J. Eikenboom¹
Abstract Number: PB1103

Identification of Tumor-expressed MicroRNAs Associated with Venous Thrombosis in Colorectal Cancer

R.J.S. Anijs¹, E.H. Laghmani¹, B. Ünlü¹, S.M. Kielbasa¹, H. Mei¹, S.C. Cannegieter¹, F.A. Klok¹, P.J.K. Kuppen¹, H.H. Versteeg¹, J.T. Buijs¹
Abstract Number: PB0555

Identify Clinical and Laboratory Phenotypes of People with Hemophilia in Southwest Nigeria

T. Adeyemo¹, A. Bolarinwa¹, L. Adiat¹, A. Olatinwo¹, O. Opadeyi¹, O. Otokiti¹, T. Youttananukorn², D. Coffin²
Abstract Number: PB0152

Identifying Tools to Track Hypercoagulability in COVID-19 Patients. Exploring Global Haemostasis (ROTEM) and Neutrophil Extracellular Traps (NETs) Immunoassays

S. Stanford¹, C. Rea², A. Roy³, B. Harris³, A. Ashton³, S. Mangles³, T. Everington³, K. Chandrakumaran³, E. Arbuthnot³, T. Cecil³
Abstract Number: PB0120

Identifying Vulnerable Patients with Direct Oral Anticoagulant (DOAC) Levels Outside the Expected Range

D. Braeken¹, R. Bavalia², Y. Henskens³, H. ten Cate^1,4, J. Veenhuizen², R. Hengeveld⁵, B. Hutten⁶, S. Middeldorp^2,7, M. Coppens², A. Stroobants²
Abstract Number: PB0834

Idiopathic Thrombocytopenic Purpura: Conventional Prednisolone vs High-dose Dexamethasone

C. Lewis^1,2, Z. Ng^1,3, C. Grove^1,2,3
Abstract Number: OC 55.1

IgG2 as Hallmark of Inhibitor Persistence in a Longitudinal Analysis of PUPs in the First 50 Exposure Days to FVIII

S. Miri¹, C. Valsecchi², L. Schiavone², A. El-Beshlawy³, M. Elalfy⁴, V. Ramanan⁵, P. Eshghi⁶, S. Hanagavadi⁷, R. Varadarajan⁸, M. Karimi⁹, F.R. Rosendaal¹⁰, P.M. Mannucci², F. Peyvandi¹¹
Abstract Number: OC 36.3

Immature Platelet Count is Associated with Platelet Functional Responses in Patients Receiving Aspirin

G. Gulati¹, D. Hughes¹, L. Goudswaard¹, I. Hers¹, A. Mumford¹, K. Burley¹
Abstract Number: PB0825

Immature Platelet Fraction in Systemic Lupus Erythematosus-Related Thrombocytopenia: Potential Predictor of Platelet Response to Treatment?

T. Nguyen¹, D. Truong-Pham¹, T. Huynh¹, T. Nguyen¹, T. Tran¹, L. Phan-Nguyen¹, G. Nguyen-Tran¹, T. Tran¹
Abstract Number: LPB0011

Immature Platelets as a Biomarker for Disease Severity and Mortality in COVID-19 Patients

D. Welder¹, H. Jeon-Slaughter¹, B. Ashraf¹, S.-H. Choi¹, W. Chen¹, I. Ibrahim¹, T. Bat¹
Abstract Number: PB0455

Immune Complex Formation of Factor VIII (FVIII) with Inhibitors is Modulated by von Willebrand Factor (vWF)

O. Oleshko¹, U. Curth², A. Tiede¹, S. Werwitzke¹
Abstract Number: PB0377

Immune Mediators in Pediatric Patients with Chronic Kidney Disease

A. Silva¹, L. Perucci², R. Silva¹, L. Sousa¹, A. Talvani², A.P. Mota¹, L. Dusse¹, P. Alpoim¹
Abstract Number: PB0269

Immune Thrombocytopenia during Covid-19 Pandemic: An Italian Monocentric Experience

G. Lapietra¹, A. Ferretti¹, E. Baldacci¹, M.L. De Luca¹, S.M. Aprile¹, F. Barone¹, S. Olivieri¹, A. Chistolini¹, C. Santoro¹
Abstract Number: PB0303

Immune Thrombocytopenia Purpura Associated with Novel Coronavirus Infection

R.M. Camelo^1,2, P.C. Gontijo^2,3,4
Abstract Number: PO128

Immune Thrombocytopenia Refractory to Corticoid Therapy Secondary to Covid-19. A Single-centre Experience

B.L. Diaz Jordan¹, V.B. Yepez Espinales¹, A. Valverde Templado¹
Abstract Number: PB1011

Immune Thrombocytopenic Purpura: A Case Report

A. Berisha¹, S. Sadiku¹
Abstract Number: PB0872

Immunofluorescence Staining of Blood Smears for the Diagnostics of Platelet Disorders: A Single-center Experience in a Pediatric Hospital

N. Podoplelova^1,2, E. Popova^3,1, P. Zharkov², D. Fedorova², A. Greinacher⁴, M. Panteleev^1,2,3
Abstract Number: PB0549

Immunogenicity and Safety of Simoctocog Alfa in Previously Treated Patients Switching to Simoctocog Alfa in the GENA Clinical Trial Programme

M.J. Manco-Johnson¹, R.J. Liesner², A. Tiede³
Abstract Number: OC 32.3

Immunogenicity in the Concizumab Phase 2 Clinical Trials: Clinical Impact of Anti-drug Antibodies

L. Hummelshøj Landsy¹, G. Castaman², K. Cepo³, P. Lenting⁴, J. Oldenburg⁵
Abstract Number: PB0138

Immunothrombosis Biomarkers for Distinguishing COVID-19 Patients from Non-COVID Septic Pneumonia Patients and for Predicting ICU Mortality

E. Cani¹, D. Dwivedi¹, K.L. Liaw², D. Fraser³, C. Yeh⁴, C. Martin³, M. Slessarev³, S. Cerroni¹, A. Fox-Robichaud¹, J. Weitz¹, P. Kim¹, P. Liaw¹, DYNAMICS and COVID-BEACONS Investigators
Abstract Number: PB1108

Impact of a Smartphrase Venous Thromboembolism Risk Assessment Tool on Prophylaxis Prescribing Rates in a Gynecologic Oncology Clinic

M. Duco¹, J. MacDonald¹, B. Orr¹, E. Weeda¹, N. Bohm¹
Abstract Number: PB1049

Impact of ABO Incompatibility on the Outcome of Hematopoeitic Stem Cell Transplantation

M. Borhany¹, U. Zaidi¹, M. Abid¹, S. Zafar¹, T. Shamsi¹
Abstract Number: PB0454

Impact of Adherence to Prophylactic Treatment on Real-world Outcomes in Adults with Severe Haemophilia: A CHESS II Analysis in Europe

T. Burke^1,2, S. Asghar¹, J. O'Hara^1,2, D. Yee³, S. Kar³
Abstract Number: LPB0061

Impact of Characteristic Inhibition Kinetics of Different FVIII Inhibitors on the Inhibitor Titer Quantification in the Modified Nijmegen-Bethesda Assay

C. Ketteler¹, I. Hoffmann¹, S. Davidson², A. Tiede³, N. Richter¹
Abstract Number: PB0252

IMPACT of COVID-19 Associated Coagulopathy in Disease Severity

F. Santos¹, R. Marinho¹, M. Carneiro¹, R. Matos¹, N. Pinho¹, L. Moreira¹, N. Seidi¹, M. Coutinho¹, S. Morais¹, E. Cruz¹
Abstract Number: PB0137

Impact of COVID-19 on Platelet Activity and the Platelet Releasate

S. Comer^1,2, S. Cullivan^1,3, P. Szklanna^1,2, L. Weiss^1,2, S. Cullen⁴, S. Kelliher⁵, A. Smolenski⁶, C. Murphy^1,7, H. Altaie⁸, J. Curran⁹, K. O'Reilly^3,6, A. Cotter^6,10,11, B. Marsh^6,12, S. Gaine^3,6, P. Mallon^6,13, B. McCullagh^3,6, N. Moran⁴, F. Ní Áinle^1,5,6,14, B. Kevane^1,5,6, P. Maguire^1,2,15
Abstract Number: PB0576

Impact of COVID-19 Pandemic on the Joint Bleeding Pattern and Prophylactic Management of Hemophilia Patients: A Single Centre Study in a Tertiary Care Centre of Eastern India

A. Chatterjee¹, A.K. De¹, M. Bera¹, S. Roy¹, A. Chowdhury¹
Abstract Number: PB0205

Impact of COVID-19 Pandemic on the Quality and Performance of Haemostasis Laboratories

R.A. Arisz¹, P. Meijer², N.CV Péquériaux³, S.J van de Leur⁴, M.V Lukens⁵, M.PM de Maat¹, M.J Hollestelle²
Abstract Number: PB0130

Impact of DNA on the Fibrin Clot Structure in Peritoneal Carcinomatosis Patients

S. Mirshahi^1,2, I. Aldybiat², G. Contant¹, M. Pocard², J. Soria², M. Mirshahi²
Abstract Number: LPB0001

Impact of Heparin Induced Thrombocytopenia on the Outcomes of Hospitalizations for Acute Myocardial Infarction: Analysis of National Inpatient Sample

M.U. Almani¹, M.J. Tariq¹, M. Usman¹, M. Qudrat Ullah², M. Yousuf³, N. Fatima⁴, E. Edigin¹, A. Vij¹, J. Gomez Valencia¹
Abstract Number: PB0713

Impact of Inherited Bleeding Disorders on Pregnancy and Postpartum Hemorrhage

N. Fernández Mosteirín¹, J.M. Calvo Villas¹
Abstract Number: PB0901

Impact of Iron Deficiency Anemia on Bleeding Management in Pediatric Patients with Bernard-Soulier Syndrome and Glanzmann Thrombasthenia: A Single-institution Analysis

A. Lee¹, G. Batsuli^1,2
Abstract Number: PB0561

Impact of Prophylactic Treatment on Employment and Disability in Persons with Hemophilia

P.A. Holme¹, C. Qvigstad¹, R.C. Tait²
Abstract Number: PB0589

Impact of Switching to Recombinant Factor IX Fc Fusion Protein Prophylaxis: A Qualitative Study

M. O'Donovan^1,2, P. Byrne¹, B. O'Mahony^3,4, K. Ryan¹, N.M. O'Connell^1,2, D. Hevey⁵
Abstract Number: PB1021

Impact of the Common GPVI Polymorphism Is Limited to Intracellular Calcium Response upon Activation

M. Stepanyan^1,2, A. Martyanov^1,3, A. Boldova¹, A. Filkova^1,3, A.K. Garzon Dasgupta^1,2, E. Beresneva¹, A. Balatsky⁴, E. Ponomarenko³, A. Ignatova^1,3, M. Panteleev^1,2,3, A. Sveshnikova^1,2,3
Abstract Number: PB0217

Impact of the COVID-19 Pandemic and a National Lockdown on Hospitalizations for Venous Thromboembolism and Pulmonary Embolism in France

A. Gabet¹, C. Grave¹, P. Tuppin², J. Emmerich³, V. Olié¹
Abstract Number: PB1156

Impact of Thrombophilia Testing in Splanchnic Vein Thrombosis Management

R. Rouached^1,2, H. Baccouche^1,2, A. Laabidi^3,2, H. Kechir^4,2, J. Boubaker^3,2, N. Laamari^4,2, N. Ben Romdhane^1,2
Abstract Number: PB1302

Impact of Tissue Factor Pathway Inhibitor Gene Polymorphisms (33T/C and 264V/M) on Plasma TFPI Levels and their Influence on Risk of Recurrent Pregnancy Loss in India

K. Kishor¹, A. Sharma¹, S. Maharana², R. Ranjan¹, R. Kumar¹, S. Tyagi¹, R. Saxena³, M. Mahapatra¹
Abstract Number: LPB0119

Impact of Vancomycin-induced Shift of the Gut Microbiome in Gram Negative Direction on Plasma Factor VIII:C Levels: Results from a Randomized, Controlled Trial

G. Grimnes^1,2, S. Bhoelan^1,3, K. Hindberg¹, M. Davids⁴, M. Nieuwdorp^4,5,6, T.E. Mollnes^1,7,8, A. Michelsen^9,10, T. Ueland^1,9,10, S. Braekkan^1,2, J.-B. Hansen^1,2, V. Tichelaar^1,3,11
Abstract Number: OC 10.2

Impairment of Platelet Purinergic Signaling in Sickle Cell Disease

T. Brzoska¹, E.V. Menchikova¹, T.W. Kaminski¹, R. Vats¹, E. Tutuncuoglu¹, S.P. Tofovic¹, E.K. Jackson¹, M.T. Gladwin¹, P. Sundd¹
Abstract Number: PB1217

Implementation of a Multidisciplinary Surveillance Team to Improve Inferior Vena Cava Filter Retrieval and Outcomes

S. Chao¹, H. Bortz², H. Stevens^3,4,5, J. McFadyen^3,4,5, H. Tran^3,4
Abstract Number: PB0696

Implementation of a National Reference Service for Activity Testing, Typing, and Genotyping of Hereditary Factor XIII Deficiency (Project BR-13)

R. Camelo¹, J. Moreira², L.I. Pires Filho³, V. Franco⁴, C.B. Ferreira⁵, L.C.C.M. de Souza⁶, M.D. Tenório⁷, S. Figueiredo⁷, S. Lopes⁸
Abstract Number: OC 07.1

Implementation of Tele-guidance for Patient Self-imaging of Arthropathic Joints Using Mobile Ultrasound Devices –– Results from a Pilot Study

P. Aguero¹, A. Flores¹, A. von Drygalski^1,2
Abstract Number: PB1009

Importance of Consideration to Differetial Diagnosis of ITP

N. Mirbehbahani¹
Abstract Number: PB0883

Importance of Platelet’s Sialic Acid Residues on Haemostasis and Immune System of Patients with Immune Thrombocytopenia

N.V. Butta Coll¹, M.T. Álvarez Román¹, E. Monzón Manzano¹, M. Martín Salces¹, M.I. Rivas Pollmar¹, E. García Arias-Salgado¹, P. Acuña¹, S. García Barcenilla¹, E. González Zorrilla¹, T. Cebanu¹, V. Jiménez Yuste¹
Abstract Number: PO133

IMPROVE Score and Coagulopathy Screening in Coronavirus Disease 2019 Patients

C. Syukur¹, H. Haroen¹, L.W.A. Rotty¹, P.F.C. Lasut¹, C. Hendrata¹, C.T.H. Kawengian¹
Abstract Number: OC 06.1

Improved Overall Survival with Warfarin Compared with Direct Oral Anticoagulants in Cancer-associated Venous Thromboembolism: A SEER-medicare Analysis

T. Chiasakul^1,2, A.M Khan¹, R. Redd³, R. Patell¹, E.P McCarthy^1,4, D. Neuberg³, J.I Zwicker¹
Abstract Number: LPB0041

Improved Patient-reported Treatment Satisfaction with Rivaroxaban as Compared to Low Molecular Weight Heparins for Cancer Patients with Acute Venous Thromboembolism – Results from the CONKO-011 Trial

H. Riess¹, M. Sinn², A. Lohneis³, M. Hellmann⁴, J. Striefler¹, T. Südhoff⁵, U. Pelzer¹, M. Stahl⁶, A. Schlenska-Lange⁷, A. Krziwanie⁸, R. Trappe⁹, S. Rutzner¹⁰, J. Heinz¹¹, K.-D. Wernecke¹²
Abstract Number: PO108

Improving of the of Biomechanical Parameters in an Experimental Animal Abdominal Aorta Model of Thick- cap Fibroatheromatic Plaque Using Ultrasound-guided High-dose Atorvastatin-loaded PESDA Microbubbles and Low Level Focused Shock Waves

H. Mehrad^1,2, H. Ahmadi Noubari^3,2
Abstract Number: OC 65.3

Improving Outcomes with Integrated Care of Patients with Atrial Fibrillation and Multimorbidity Using Mobile Health Technology: A Report from the mAFA II Trial

Y. Guo¹, G.YH Lip²
Abstract Number: NUR 01.3

Improving Post-Thrombotic Syndrome (PTS) Care in Children: A Child’s Voice

J. Vincelli¹, L.R. Brandao¹, N. Amiri¹, R. De¹, S. Williams¹, L. Avila¹
Abstract Number: PB0793

In Children Receiving Long-term Anticoagulation Decreased Bone Mineral Density is Associated with Pubertal Development

K. Thom¹, C. Male¹, F. Haufler¹, A. Raimann¹
Abstract Number: PB0566

In vitro Analysis of Coagulation Function in Emicizumab-treated Hemophilia A Patients with Inhibitors under Immune Tolerance Induction Treatment

Y. Nakajima¹, H. Tonegawa¹, M. Noguchi-Sasaki², K. Nogami¹
Abstract Number: PB0362

In vitro Neutralization of Unfractionated Heparin for the Measurement of Thrombin Generation with the STG-drugScreen Reagent on ST Genesia

S. Fontaine¹, M. Bourdin¹, M.-A. Bildan¹, O. Kerleau¹, M. Lambert¹, F. Depasse², O. Mathieu¹
Abstract Number: PB1082

Inappropriate Direct Oral Anticoagulant Dosing in a Spanish Cohort with Atrial Fibrillation

B. Navarro Almenzar¹, J.J. Cerezo Manchado², F. García Candel³
Abstract Number: PB0763

Incidence and Correlation of Thrombocytopenia to Blood Stream Infections; Does this Correlation Really Matter?

N. Anwar¹, N. Fatima¹, H.-u.- Mujtaba¹, T. Shamsi¹
Abstract Number: PB1100

Incidence and Impact of Venous Thromboembolism and Major Bleeding in Patients with Glioblastoma

F.H.J. Kaptein¹, M.A.M. Stals¹, E. Klaase¹, M.Y. Kapteijn¹, R. van Eijk², S.C. Cannegieter^1,3, S.G. van Duinen², M.J.B. Taphoorn^4,5, L. Dirven^4,5, H.H. Versteeg¹, J.T. Buijs¹, M.V. Huisman¹, J.A.F. Koekkoek^4,5, F.A. Klok¹
Abstract Number: OC 64.4

Incidence and Predictors of Post-thrombotic Syndrome: Results from GARFIELD-VTE

P. Prandoni¹, A.E. Farjat², S. Haas³, A.G. Turpie⁴, H. Bounameaux⁵, S. Schellong⁶, S.Z. Goldhaber⁷, G. Kayani², M. Carrier⁸, B. Jacobson⁹, W. Ageno¹⁰, J.I. Weitz¹¹, S. Goto¹², P. Angchaisuksiri¹³, L.G. Mantovani^14,15, A.K. Kakkar^2,16
Abstract Number: PB1207

Incidence and Treatment Pattern of Venous Thromboembolism from 2014 to 2018: The 3rd Korean Nationwide Study

H.-G. Hwang¹, J.H. Lee², S.-A Kim², Y.-K. Kim³, H.-Y. Yhim⁴, J. Hong⁵, S.-M. Bang².
Abstract Number: PB0438

Incidence Comparison and The Antiplatelet Effect on Bleeding Risk Between Chronic Kidney Disease Undergoing Haemodialysis and Peritoneal Dialysis: A Meta-analysis of Cohort Studies

B.P. Putra¹, F.N. Putra²
Abstract Number: PB0267

Incidence of Disseminated Intravascular Coagulation (DIC) in Critical Patients with Covid-19

C.F. Hernandez Mata¹, N. Fernández Mosteirín¹, I. Sancho Val¹, M.d.M. Herrero Gutierrez¹, A. Esteban Molina¹, M. Peiro Chamarro¹, A. Gómez Martínez¹, S. Martín-Consuegra Rámos¹, M. Moreno Carbonell¹, M. Civeira Marín¹, E. González Gómez¹, C. Rodríguez Lefler¹, A. López Peña¹, M.S. Ordas Miguelez¹, P.E. Lopez Gomez¹, J.M. Calvo Villas¹
Abstract Number: PB0860

Incidence of Heparin Induced Thrombocytopenia 2009-2017: Analysis of the National Inpatient Sample Database

Y. Hayashi-Tanner¹, M. Gaddam¹, S. Frankki¹, A. Borgert¹, L. Rosenstein¹
Abstract Number: PB0861

Incidence of Heparin-induced Thrombocytopenia in Patients Treated with Mechanical Circulatory Support: Results from a Prospective Study

A. Gaupp¹, O. Hidiatov¹, S. Nowak-Harnau², A. Straub^3,4, H. Häberle³, P. Rosenberger³, T. Bakchoul^1,2, K. Althaus^1,2
Abstract Number: PB0302

Incidence of Spontaneous Iliopsoas Hematoma in COVID-19 Patients

G. Sottilotta¹, C. Mangano², R. Basile², C. Falcone³, F. Luise⁴, D. Megalizzi¹, G.M. Nicolò⁵, V. Oriana¹, A. Piromalli⁴
Abstract Number: PB1231

Incidence of Thrombohaemorrhagic Complications in the Periprocedural of Oral Anticoagulant Treatment with Vitamin K Antagonists

M. Argüello Marina¹, I. Gutiérrez Jomarrón¹, L. Castilla García¹, E. Flores Ballester¹, I. Sánchez Prieto¹, S. Valenciano Martínez¹, J.M. Aspa Cilleruelo¹, C. Martínez Vázquez¹, G. López de Hontanar Torres¹, P.A. Rodríguez Barquero¹, M. López Rubio¹, J. García Suárez¹
Abstract Number: PB1166

Incidence of Thrombosis in Patients with MTHFR C677T Homozygosity and Hyperhomocysteinemia

G.M. Nicolò¹, G. Sottilotta², F. Luise³, V. Oriana², A. Piromalli³
Abstract Number: PB1206

Incidence of Venous Thromboembolic Disease during Primary Hyperparathyroidism: A 20-year Single Center Study

M. Orlova¹, Y.J. Zin¹, M.L. Posadas Martínez¹, M.F. Grande Ratti¹, D.H. Giunta¹, M. Burgos¹, F.J. Vázquez¹
Abstract Number: PB0505

Incorporating Patient Reported Outcomes into Clinical Practice: A 360-degree Clinical Evaluation for Better Care and Treatment of People with Hemophilia through myWBDR and myPROBE

T. Youttananukorn¹, D. Coffin¹, S. Diop², C. Hermans³, B. Konkle⁴, C. Lambert⁵, D. Noone⁶, J. O'Hara⁷, G. Pierce¹, M.W Skinner^8,9, A. Iorio¹⁰
Abstract Number: PB0916

Increased Cleavage of VWF by ADAMTS13 Might Reduce High-molecular-weight VWF Multimers, Leading to Acquired von Willebrand Syndrome in Patients with Essential Thrombocythemia

M. Kubo^1,2, H. Kashiwagi³, H. Yagi⁴, Y. Seki⁵, A. Hasegawa², H. Tanaka², I. Amano², Y. Tomiyama⁶, M. Matsumoto¹
Abstract Number: OC 17.2

Increased Levels of Coagulation Factor V in Atherosclerotic Plaques – An Immune Regulated Response?

B. Stavik¹, M. Seierstad Andresen¹, S. Holm¹, M. Skjelland^1,2, M. Tinholt¹, P.M. Sandset^2,2, N. Iversen¹, B. Halvorsen^1,2
Abstract Number: OC 33.3

Increased Plasma Concentration of Pentraxin 3 and Fibroblast Growth Factor 2 in Preeclampsia

F. Santiago de Oliveira¹, L. de Oliveira Perucci², L. Maria Sant'Ana Dusse¹, P. Nessralla Alpoim¹, A. Abalen Martins Dias¹
Abstract Number: PB0496

Increased Prevalence of Age-related Comorbidities and Health Service Utilization among Adult Men with Hemophilia in Alberta, Canada

A.U. Alam¹, C. Wu¹, H. Sun¹
Abstract Number: PB0705

Increased Risk for Re-bleeding after Hemostatic Challenges in Patients with a Mild to Moderate Bleeding Tendency

D. Mehic¹, G. Neubauer¹, A. Kaider², C. Ay¹, I. Pabinger¹, J. Gebhart¹
Abstract Number: PB0146

Increased Thrombin Generation in COVID-19 is Mediated by Platelet-dependent and -Independent Mechanisms

A.S. Eustes¹, J. Swamy¹, S. Kudchadkar¹, M. Jensen¹, K.M. Wilson¹, U. Perepu¹, F. Miller², S.R. Lentz¹, S. Dayal¹
Abstract Number: PB0198

Increased von Willebrand Factor (VWF) and Factor VIII (FVIII) Levels in Severe Acute Respiratory Syndrome Sars-Cov2-positive Pneumonia Compared with Severe Acute Respiratory Syndrome Sars-Cov2-negative: A Case-control Study

M. Sacco¹, R. De Cristofaro^2,1, G. Liuzzo³, S. Lancellotti², D. Pedicino³, F. Andreotti³
Abstract Number: PB0242

Indices of the Hemostasis System in Patients with COVID-19 Depending on the Outcome

E. Klychnikova¹, S. Petrikov¹, K. Popugaev¹, E. Tazina¹, S. Badygov¹
Abstract Number: OC 57.2

Individual Benefits and Harms of Extended Anticoagulation in Patients with Venous Thromboembolism: The VTE-PREDICT Model

M.A. de Winter¹, J.A.N. Dorresteijn², M. Carrier³, A.T. Cohen⁴, J.-B. Hansen⁵, H.A.H. Kaasjager¹, S. Middeldorp⁶, G.E. Raskob⁷, H.T. Sørensen⁸, F.L.J. Visseren², P.S. Wells³, H.R. Büller⁹, M. Nijkeuter¹
Abstract Number: PB0046

Induced Forms of α₂-Macroglobulin Neutralize Heparin and Direct Oral AntiCoagulant Effects

G. Jourdi^1,2,3,4, J. Abdoul¹, V. Siguret^1,5, X. Decleves^6,2, E. Frezza⁷, C. Pailleret^1,8, I. Gouin-Thibault^9,10, S. Gandrille^1,11, N. Neveux², C.-M. Samama^1,2, S. Pasquali⁷, P. Gaussem^1,11
Abstract Number: PB0648

Infectious Complications in Hemophilia Patients

H. Khachatryan^1,2,3, G. Tamamyan^1,2, I. Melnichenko^1,2, L. Sahakyan¹, L. Petrosyan¹, S. Danelyan¹, S. Hovhannisyan^1,2, A. Movsisyan^1,2, L. Hambardzumyan^1,2, N. Sargsyan^4,2,3
Abstract Number: PB0460

Influence of Activated Factor XI on Simultaneous Thrombin Generation and Fibrin Clot Lysis in Factor Deficiencies

I. Tarandovskiy¹, W.C. Chang¹, M. Ovanesov¹
Abstract Number: PB0243

Influence of C-reactive Protein on Thrombin Generation Assay

M. Didembourg¹, J. Douxfils^1,2, F. Mullier³, M. Hardy⁴, J. Favresse^1,5, L. Morimont^1,2
Abstract Number: PB0061

Influence of Low-generation Polyamidoamine (PAMAM) Dendrimers on Structure and Function of Fibrinogen, Generation, Amidolytic and Coagulating Activity of Thrombin in vitro

L. Mukhametova^1,2, R. Aisina¹, E. Ivanova¹
Abstract Number: PB0069

Influence of Para-sulfonato-calixarenes on Components of Coagulation System

E. Ivanova¹, R. Aisina¹, K. Gershkovich²
Abstract Number: PB0621

Influence of Pregnancy on the Pharmacokinetic Profile of a Severe Hemophilia A Female

L. Costa¹, A. Ferreira¹, M. Coutinho¹, M. Pereira¹, E. Cruz¹, S. Morais¹
Abstract Number: PB0062

Influence of Tissue-factor Pathway Inhibitor on Thrombin Generation Assay

M. Didembourg¹, J. Douxfils^1,2, A. Carlo³, L. Morimont^1,2
Abstract Number: PB0802

Inherited Antithrombin Deficiency in Childhood: A Multicenter National Study

A. Unuvar¹, N. Sarper², U. Demirsoy², I. Eker³, N. Eroglu³, Z. Kaya⁴, D. Aslan⁴, N.O. Karadas⁵, K. Kavakli⁵, N. Ozbek⁶, N. Yarali⁶, A. Canbolat⁷, T. Celkan⁸, M. Evim⁹, S. Karaman¹, H. Oren¹⁰
Abstract Number: PB0719

Inherited Factor XIII Deficiency: A Mild and a Severe Case Reports

A.C. Gusmão¹, N.N.S. Magalhães¹, R.D.M. Almeida¹, A.C.A. Santos², T.S. Espósito², L.O.W. Rodrigues³, O.F. Santos⁴, J.A.S. Lopes⁴, D.O.W. Rodrigues^5,2
Abstract Number: OC 43.3

Inhibition of ADAMTS13 Rescues Acquired von Willebrand Syndrome in a Preclinical Left Ventricular Assist Device Animal Model

S.J Deconinck¹, C. Nix², S. Barth², E. Bennek-Schöpping², A.-S. Schelpe¹, E. Roose¹, I. Pareyn¹, A. Vandenbulcke¹, J. Muia³, C. Vandenbriele⁴, B. Meyns⁵, C. Tersteeg¹, S.F De Meyer¹, S. Jacobs⁵, K. Vanhoorelbeke¹
Abstract Number: PB0995

Inhibition of ADP and Thromboxane A2 Production Results in Decreased Global Platelet Contraction, but Thromboxane A2 Inhibition Plays a Greater Role in Limiting Local Platelet Contraction

K. Trigani¹, S. Diamond¹
Abstract Number: OC 28.1

Inhibition of Neutrophil Extracellular Traps Reveals their Differential Role in the Pathogenesis of Abdominal Aortic Aneurysms in Distinct Mouse Models

N. Ibrahim¹, S. Bleichert¹, J. Klopf¹, V. Knöbl¹, A. Brandau¹, A. Busch^2,3, M. Bailey^4,5, W. Eilenberg¹, C. Neumayer¹, C. Brostjan¹
Abstract Number: LPB0131

Inhibition of Surface-induced Platelet Activation on Hydrogel Films

G. Apte¹, A. Lindenbauer¹, J. Schemberg¹, H. Rothe¹, T.-H. Nguyen¹
Abstract Number: OC 73.1

Inhibition of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) to Accelerate Clot Lysis in Patients with Acute Pulmonary Embolism: A Phase 2 Randomized Study

T. Vanassche¹, R.P Rosovsky², F. Moustafa^3,4, H.R Büller⁵, A. Segers⁶, I. Patel⁷, M. Shi⁸, N. Miyoshi⁹, V. Mani¹⁰, Z. Fayad¹⁰, J. Schmidt^3,4, M.A Grosso⁷, V.F Tapson¹¹, P. Verhamme¹, M.V Huisman¹², DS1040 Study Group
Abstract Number: PB0500

Inhibitor Development upon Switch from Plasma-derived to Recombinant FVIII in PUPs with Severe Haemophilia A: Preliminary Analysis from the PUP-SWITCH Study

S. Miri¹, R.K. Kavakli², S. Halimeh³, G. Nicolò⁴, D. Gürlek Gökçebay⁵, N.Y. Özbek⁵, T. Celkan⁶, M. Karimi⁷, A. Shahsavani⁷, B.T. Gunes⁸, B. Atabay⁸, Z. Kaya⁹, Y. Ay¹⁰, Y. Oymak¹¹, S. Akbayram¹², B. Yılmaz¹³, E. Kazanci¹⁴, P.M. Mannucci⁴, F.R. Rosendaal¹⁵, F. Peyvandi¹⁶, PUP-SWITCH Study Group
Abstract Number: PB0647

Inhibitors in Non Severe Haemophilia A (NS-HA): A Case Report

M. R. Lopez¹, E. Lopez Ansoar¹, O. Dominguez Muñiz¹, A. Nieto Vazquez¹, C. Albo Lopez¹
Abstract Number: OC 28.2

Innocuous Levels of Pulmonary Thrombosis Protect against Inflammatory Lung Injury via Endothelial Alox15 and HIF1α

C. Evans¹, X. Zhang¹, N. Machireddy¹, Y.-Y. Zhao¹
Abstract Number: PB1170

Inpatient Thrombophilia Testing – Adding Unnecessary Cost to the Clot?

S. Bandikatla¹, A. Dadlani¹, A. Pinter¹, S. Maharaj², A. Rojan²
Abstract Number: PB1024

Integrin αIIbβ3 Regulates Platelet Procoagulant Activity in the Lung

T. Brzoska¹, T.W. Kaminski¹, R. Vats¹, E. Tutuncuoglu¹, M.T. Gladwin¹, P. Sundd¹
Abstract Number: OC 19.4

Interaction between the Von Willebrand Factor and ADAMTS13 on VTE Risk in Women. Results from the Retrove Project

D. Llobet¹, C. Vallvé¹, S. Mojal¹, M. Carrasco¹, N. Vilalta¹, J. Mateo¹, M. Corrochano¹, J.A. Millón¹, J.C. Souto¹
Abstract Number: PB1006

Interaction of Blood Platelets with Engineered Fibrinogen Scaffolds of Different Topographies

M. Kenny¹, S. Stamboroski^2,3, R. Taher¹, D. Brüggemann², I. Schoen¹
Abstract Number: PB0122

Interaction of Phenyramidol HCl and Warfarin: A Case Series Report

B. Murat¹, E. Kivanc¹, R. Dizman¹, S. Murat²
Abstract Number: PB0103

Interaction of the Factor IXa with the Subpopulations of Activated Platelets

P.A. Soloveva^1,2, N.A. Podoplelova^1,3, F.I. Ataullakhanov^1,2,3,4, M.A. Panteleev^1,2,3,4
Abstract Number: PB1297

Interactions of Anemia with Race and Peripartum Transfusion in Three Large US Registries

E. Davis¹, R. Amdur², H. Ahmadzia³
Abstract Number: PB0506

Interim Analysis of the PREVENT Study: Real World Prospective Data from Children and Adolescents with Haemophilia A or B Treated with Recombinant Factor VIII Fc (rFVIIIFc) or Recombinant Factor IX Fc (rFIXFc)

C. Heller¹, C. Bidlingmaier², C. Escuriola³, N. Hagedorn⁴, J. Oldenburg⁵, J. van den Boom⁶, H. Malmström⁷, E. Santagostino⁸, A. Tiede⁹
Abstract Number: OC 28.3

Interleukin-4 Signaling Enhances Survival of Circulating Monocytes in vivo

P. Haider¹, J. Kral-Pointner^1,2, M. Salzmann¹, S. Bleichert¹, W. Schrottmaier¹, C. Kaun¹, M. Brekalo¹, C. Hengstenberg¹, M. Fischer^1,3, W. Speidl¹, K. Huber^4,5, S. Knapp^1,6, F. Brombacher⁷, C. Brostjan¹, J. Wojta^1,2, P. Hohensinner^1,2
Abstract Number: PO111

Intermediate Stage Atherosclerosis Regression Using Lipid-based Encapsulated Methotrexate Nanoparticles-mediated B-mode Ultrasound-guided Pulsed Low Level Focused Ultrasound Sonoporation Therapy

H. Mehrad^1,2, M. Kasiri²
Abstract Number: PB0948

Intermittent Prophylaxis for Heavy Menstrual Bleeding in Von Willebrand Disease

P. Laguna¹, A. Laguna², M. Matysiak¹
Abstract Number: PB1267

International Multicentric Study: Laboratory in Patients Treated with Apixaban or Rivaroxaban in Latin America (Larila): Final Results

E. Cortina^1,2, D. Garcia^3,2, G. Conte^4,2, M.C. Guillermo^5,2, M. Cúneo^4,2, P. Turcatti^5,2, R. Izaguirre^1,2
Abstract Number: PB1229

International Survey of Secondary Thromboprophylaxis Practice Patterns in Pediatrics

H.P. Wilson¹, R. Capio¹, I. Aban¹, N. Goldenberg²
Abstract Number: PB0581

Intracranial Haemorrhage (ICH) in Egyptian Children with Haemophilia A and B: A 15 Year Retrospective Single Center Study

M. Abdelwahab¹
Abstract Number: PB0610

Intracranial Hemorrhage in Hemophiliac Patients at Chiang Mai University Hospital: A 10-year Retrospective Study

J. Khamyuang¹, P. Charoenkwan¹, L. Satitsamitpong¹, S. Sittipreechacharn¹, C. Chai-Adisaksopha¹, R. Natesirinilkul¹
Abstract Number: LPB0078

Intracranial Involvement and Neurologic Manifestations in Lemierre Syndrome: Analysis of 712 Patients

L. Valerio¹, T. Nicoletti², G. Corsi³, S. Granziera⁴, M. Jankowski¹, A. Pecci⁵, C. Sacco⁶, F. Zane⁷, S.V. Konstantinides¹, S. Barco⁸
Abstract Number: LPB0030

Investigating Impact of von Willebrand Factor Deficiencies on the Biogenesis of Weibel-Palade Bodies and Endothelial Cells Signaling Pathways

H. Yadegari^1,2, M.A. Jamil², N. Marquardt², O. El-Maarri², J. Oldenburg²
Abstract Number: PB0920

Investigating Pathomolecular Mechanisms von Willebrand Disease Variants Located in a Domains of the von Willebrand Factor

H. Yadegari¹, A. Biswas¹, S. Sadangi¹, J. Oldenburg¹
Abstract Number: OC 66.1

Investigating the Resistance of ADAMTS13 towards Protease Inhibitors

K. Singh^1,2, S. Sohrabipour^1,2, H. Madarati^1,2, T. Sparring^1,2, C. Kretz^1,2
Abstract Number: PB1034

Investigation of Core and Shell Platelet Mechanics through P2Y₁₂ Antagonism

M. DeCortin¹, S. Diamond¹
Abstract Number: OC 75.2

Investigation of Early Outcomes Following Adeno-associated Viral Gene Therapy in a Canine Hemophilia Model

P. Batty¹, B. Yates², D. Hurlbut¹, S. Siso-Llonch², A. Menard³, H. Akeefe², T. Christianson², P. Colosi², L. Harpell¹, S. Liu², A. Mo¹, A. Pender¹, G. Veres², C. Vitelli², A. Winterborn⁴, S. Bunting², S. Fong², D. Lillicrap¹
Abstract Number: PO169

Investigation of Hereditary Thrombophilia in Women with Recurrent Fetal Loss in LUMHS Hyderabad

K. Ilyas¹, I. Ujjan¹, B. Bhatti¹, A. Naz¹, S. Abbasi¹
Abstract Number: OC 20.2

Investigation of Preterm Intraventricular Hemorrhage Induced Inflammatory Response and microRNA Levels by Heme and Hypoxia in Human Choroid Plexus Epithelial Cells

Z. Fejes¹, M. Pócsi¹, A. Balla¹, E. Balogh², A. Tóth², V. Jeney², Á. Rusznyák³, F. Fenyvesi³, A. Nagy⁴, J. Kappelmayer¹, B. Nagy Jr.¹
Abstract Number: PB0010

Investigation of Red Blood Cells Influence on Atherosclerotic Plaque by Scanning Flow Cytometry

E. Yastrebova^1,2, A. Karpenko²
Abstract Number: PB0899

Investigation of the Epidemiology of Inherited Platelet Disorders in Patients Attending the Royal Hospital, Muscat, Oman

R. Al Ghaithi¹, S. Al Hashami¹, N. Al Amri¹, S. Al Shiyadi¹, R. Al Lawati¹, R. Al Busaidi¹, H. Ambusaidi¹, S. Al Lamki², M. Al Yahyai¹, M. Al Riyami¹, M. Al Musalhi¹, I. Al Salmi³
Abstract Number: PB0867

Investigations of the Impact of Sialidase-mediated Changes on Bleeding Using a Humanized in vivo Mouse Model

L. Pelzl¹, A. Singh¹, J. Zlamal¹, I. Marini¹, K. Althaus^1,2, T. Bakchoul^1,2
Abstract Number: PB0991

Iron Repletion Decreases Platelet Count in Iron Deficient Premenopausal Women

B. Elstrott¹, H.H.S. Lakshmanan², J. Aslan², J.J. Shatzel^3,2
Abstract Number: PB1139

Is Hematopoietic Clonality of Indetermined Potential a Risk Factor for Pulmonary Embolism?

S. Soudet¹, G. Jedraszak¹, O. Evrard¹, L. Garcon¹, J.P. Marolleau¹, M.A. Sevestre¹.
Abstract Number: PB0015

Is Microvessel Perfusion Associated with Platelets in Acute Cerebrovascular Disorders?

P.P. Wadowski¹, C. Schörgenhofer², T. Rieder², S. Ertl¹, J. Pultar¹, W. Serles³, T. Sycha³, F. Mayer³, R. Koppensteiner¹, T. Gremmel¹, B. Jilma²
Abstract Number: PB0273

Is Procalcitonin Involved on the Severity of COVID-19?

A. Zakeri¹, S. Matin¹, E. Rezaei Ghalechi²
Abstract Number: LPB0143

Is standard dose thromboprophylaxis (TP) as recommended by the Royal College of Obstetricians and Gynaecologists (RCOG) adequate in pregnancy for women with prior venous thrombo-embolism (VTE)?

E. Treharne¹, A. Alexander², E. Jackson², B. Myers³
Abstract Number: PB0474

Is Standardisation the Key? FVIII Inhibitor Results: A UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) Exercise

A. Lowe¹, S. Kitchen¹, I. Jennings¹, I. Walker¹
Abstract Number: PO113

Is There an Association of Diffuse Large B-cell Lymphoma with Coronary Artery Disease?

H. Holik^1,2, B. Coha¹
Abstract Number: PB0161

Is Viscoelastometric Testing a Good Tool to Assess Hemostasis of COVID-19 Patients?

M. Bareille¹, M. Hardy², T. Lecompte³, F. Mullier¹
Abstract Number: PB0484

Is Zero Bleeds a Realistic Goal for Hemophilia Patients in the Real World Setting?

A. Adramerina¹, A. Teli¹, S. Symeonidis¹, A. Nianiu¹, M. Economou¹
Abstract Number: PB0539

Is Zero Bleeds in PWH an Achievable Goal? 3 Years of Emicizumab in Persons with Hemophilia A and Inhibitors in a Portuguese Hemophilia Treatment Centers

S. Campaniço¹, F. Rodrigues¹, A. Pereira¹, E. Rocha², G. Cevadinha², C. Catarino¹
Abstract Number: PB1176

ISTH Definition of Pulmonary Embolism-related Death and Classification of the Cause of Death in Venous Thromboembolism Studies: An Autopsy Study

T. Tritschler¹, S.P. Salvatore², S.R. Kahn^3,4, D. Garcia⁵, A. Delluc⁶, N. Kraaijpoel⁷, N. Langlois⁶, P. Girard⁸, G. Le Gal⁶
Abstract Number: PB1209

ISTH Membership and Research Output: A Comparative Study of Sub-Saharan Africa and Europe

E. Olayemi¹, D. Fiawoo²
Abstract Number: OC 33.1

ISTH Registry on Pregnancy and COVID-19 Associated Coagulopathy (COV-PREG-COAG) – First Report

S. Kazi¹, M. Othman^2,3, R. Khoury^4,5, P. Bernstein⁶, J. Thachil⁷, E. Ciantar⁸, M. Netto⁹, L. Ferrara⁹, R. Abdul-Kadir^9,10, A. Malinowski^11,12
Abstract Number: PB0169

ITP Secondary to COVID-19: A Comprehensive Review of Reported Cases

B. Berger¹, G. Rodgers²